|
Press Release: Bioquell invests for future growth
Automated filling and capping systems Ten steps to preventing infection in hospitals... Award by the NHS Purchasing and Supply Agency to BIOQUELL DoH & PASA Publish report on Success of BIOQUELL System in Showcase Hospital Programme BIOQUELL assist with clean up BIOQUELL Launch new Clarus L2 HPV Generator Briefing on the outbreak of Swine Influenza Virus BIOQUELL takes top prize at the Department of Health HCAI Technology Innovation Summit BBC News Films 'New Weapons Against Hospital Bugs' at Lewisham Hospital Department of Health Press Release Robot set to tackle killer hospital bugs BIOQUELL moves to newly renovated production facility Infection Control & Hospital Epidemiology Article - Impact of Hydrogen Peroxide Vapor Room Decontamination on Clostridium difficile... BIOQUELL technology showcased in seven NHS hospitals Best foot forward for cleaner hospitals East Sussex Hospitals NHS Trust Commence Deployment of RBDS Proactive Team Gloucestershire Hospitals NHS Foundation Trust are the first UK hospital to deploy a BIOQUELL Proactive team. "Hydrogen Peroxide Vapor can control Nosocomial MRSA Outbreak" - Clinical Infectious Diseases Article Rapid Review Panel upgrades BIOQUELL technology to Level One Status Department of Health Post BIOQUELL Case Studies as "Best Practice" on website Award of Joint Material Decontamination System (US military) sub-contract Deep Cleaning Service from BIOQUELL Category III decontamination service launched |
Micro News Spring 2009 1. MRSA everywhere: toilets, stethoscopes, uniforms, air, pagers, ambulances and elephants! Many articles have been published this spring identifying MRSA in all sorts of places including:
2. What’s lurking on the keyboard? C. difficile spores are excreted and result in widespread contamination during episodes of C. difficile infection (CDI). However, a recent study in the Cleveland VA, USA, investigated C. difficile contamination outside of the rooms of patients with CDI (Dumford, III et al. 2009). 16% of 105 non-isolation rooms and 23% of 87 surfaces in communal areas including portable medical equipment were contaminated, providing evidence that C. difficile contamination may be more widespread than expected in the hospital environment. 3. VRE: at the seaside, improved cleaning and diarrhoea The discovery of VRE around infected or colonised patients in hospital would be no surprise. However, 7% of 227 Enterococcus spp. isolates from beach water and sand were resistant to vancomycin in a recent US study (Roberts et al. 2009). The study raises uneasy questions about how widely the vancomycin resistance genes have spread in the natural Enterococcus spp. population. There have been several studies this spring investigating VRE contamination in hospitals. A study from Chicago, Illinois, suggests that improved cleaning can reduce the frequency of VRE contamination, although 8% of sites remained contaminated after cleaning (Hota et al. 2009). A study from the Cleveland VA shows that up to 38% of the sites in the rooms of patients with VRE are contaminated, and that the frequency of contamination is greater during episodes of diarrhoea (Sethi et al. 2009). 4. A problem to get your teeth into Several studies have investigated the relationship between C. difficile and MRSA in animals and animal products. An Austrian study identified C. difficile in 4% of 187 samples from animals in abattoirs, but none from retail meat (Indra et al. 2009). Perhaps more worryingly, a study from California identified MRSA in 5% of 120 retail meat samples (Pu et al. 2009). Are you watching what you eat? 5. New drugs: Lantibiotics and flower power With the Pharmaceutical antibiotic discovery pipeline continuing to slow, novel antimicrobial approaches are necessary to keep up with drug resistance in hospital pathogens. A recent review on lantibiotics, peptide bacteriocins produced by certain Gram-positive bacteria, has highlighted the antibiotic potential of these substances. Certain lantibiotics are already used as food preservatives, so may be useful to treat human disease (Piper et al. 2009). Most antibiotics originate from microbes, but plants have antimicrobial properties too. A study of several plants used in Thai medicine has identified one plant, Garcinia mangostana, with impressive antimicrobial activity against MRSA (Chomnawang et al. 2009). However, it’s a long way from in vitro antimicrobial properties to a safe, effective drug! 6. MRSA, the media and the public: an uneasy relationship No matter where you live, MRSA will have been in the media lately – but does this have any effect on the treatment of MRSA patients? A recent American study shows that media coverage of MRSA in New York increased 10-fold in October 2007, coinciding with a 6-8 fold increase in MRSA related internet search terms from the public and a 79% increase in patients’ concern over MRSA expressed to providers, although these correlations were not noted in areas of low socioeconomic status (Hahn et al. 2009). Furthermore, there was a two-fold increase in the number of skin and soft tissue infections cultured, suggesting physician behavior has also been modified, which has implications for the case ascertainment of community MRSA. A Scottish study has investigated knowledge of MRSA among patients, visitors and members of the general public (Easton et al. 2009). Encouragingly, almost 90% of the 1000 respondents had heard of MRSA, 59% knew that it was a bacterium and 47% understood the concept of colonization. However, 7% thought that MRSA was untreatable and most estimates of MRSA prevalence were much higher than actual prevalence! 7. Modelling CA-MRSA as a cause of hospital infection Community strains of MRSA have emerged as a common cause of hospital infection in the USA, in certain parts of Europe and as a cause of outbreaks in the UK (Boyce 2008). A model developed by Harvard scientists predicts that CA-MRSA, in particular USA300, will replace traditional healthcare-associated strains of MRSA in hospitals as a result of the expanding community reservoir (D'Agata et al. 2009). However, the model also predicted that hand hygiene, screening and isolation are effective control strategies for CA-MRSA in hospitals. 8. Where is USA300 CA-MRSA in the UK? USA300 dominates the CA-MRSA landscape in the USA and has begun to supplant traditional healthcare associated strains. However, a recent study presents a picture of clonal diversity among CA-MRSA in London (Otter et al. 2009). CA-MRSA presenting at hospitals in the US and in the UK was compared and CA-MRSA was more common in the US hospital, US isolates tended to affect younger patients, who were more frequently black or Hispanic and were more likely to be USA300 strains cultured from abscesses. The reasons for these differences are not clear, but may have important control implications. 9. A PVL vaccine? The role of the Panton-Valentine leukocidin (PVL) in CA-MRSA disease has been the subject of intense debate of late. A recent study from an American / French research group demonstrates that PVL contributes to necrotising pneumonia and skin infection in mice, and found that vaccination with PVL was protective against disease in the models used (Brown et al. 2009). This raises the interesting possibility of a PVL vaccine, which may reduce the chances of the most severe CA-MRSA disease. 10. A one-size-fits-all diagnostic and typing method? Sequence-based typing methods such as spa typing and MLST have provided useful insight into the population biology of various nosocomial pathogens. However, these methods are not rapid enough for routine diagnostics and typing. A new method using Raman spectroscopy, an optical fingerprinting method, could be a one-size-fits-all diagnostic and typing platform. A recent Dutch study demonstrates that Ramen spectroscopy has equal discriminatory power compared with pulsed-field gel electrophorsis (PFGE) for MRSA and could become a standard real-time typing system (Willemse-Erix et al. 2009). And finally…Outbreak? Google it!… ‘To google’ has as become a common verb. It seems that Google could also be a useful way to rapidly identify outbreaks of Influenza, according to a study by Google employees and the CDC published in Nature (Ginsberg et al. 2009). The study compared the ability of the number of Influenza-like Google hits (e.g. “flu”, “cold/flu remedy”) with the standard CDC rapid reporting method and found that the Google method was a more rapid estimation of Influenza activity! To download and print Micro News, Click here... References CDC (2009) Methicillin-resistant Staphylococcus aureus skin infections from an elephant calf--San Diego, California, 2008. MMWR Morb. Mortal. Wkly. Rep. 58, 194-198. Boyce,J.M. (2008) Community-associated methicillin-resistant Staphylococcus aureus as a cause of health care-associated infection. Clin. Infect Dis. 46, 795-798. Brady,R.R., Verran,J., Damani,N.N. and Gibb,A.P. (2009) Review of mobile communication devices as potential reservoirs of nosocomial pathogens. J Hosp Infect. Brown,E.L., Dumitrescu,O., Thomas,D., Badiou,C., Koers,E.M., Choudhury,P., Vazquez,V., Etienne,J., Lina,G., Vandenesch,F. and Bowden,M.G. (2009) The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300. Clin Microbiol Infect 15, 156-164. Chomnawang,M.T., Surassmo,S., Wongsariya,K. and Bunyapraphatsara,N. (2009) Antibacterial activity of Thai medicinal plants against methicillin-resistant Staphylococcus aureus. Fitoterapia 80, 102-104. D'Agata,E.M., Webb,G.F., Horn,M.A., Moellering,R.C., Jr. and Ruan,S. (2009) Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals. Clin Infect Dis 48, 274-284. Dumford,D.M., III, Nerandzic,M.M., Eckstein,B.C. and Donskey,C.J. (2009) What is on that keyboard? Detecting hidden environmental reservoirs of Clostridium difficile during an outbreak associated with North American pulsed-field gel electrophoresis type 1 strains. Am J Infect Control 37, 15-19. Easton,P.M., Marwick,C.A., Williams,F.L., Stringer,K., McCowan,C., Davey,P. and Nathwani,D. (2009) A survey on public knowledge and perceptions of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 63, 209-214. Fenelon,L., Holcroft,L. and Waters,N. (2009) Contamination of stethoscopes with MRSA and current disinfection practices. J Hosp Infect 71, 376-378. Gaspard,P., Eschbach,E., Gunther,D., Gayet,S., Bertrand,X. and Talon,D. (2009) Meticillin-resistant Staphylococcus aureus contamination of healthcare workers' uniforms in long-term care facilities. J Hosp Infect 71, 170-175. Gehanno,J., Louvel,A., Nouvellon,M., Caillard,J.F. and Pestel-Caron,M. (2009) Aerial dispersal of meticillin-resistant Staphylococcus aureus in hospital rooms by infected or colonised patients. J Hosp Infect 71, 256-262. Giannini,M.A., Nance,D. and McCullers,J.A. (2009) Are toilet seats a vector for transmission of methicillin-resistant Staphylococcus aureus? Am J Infect Control. Ginsberg,J., Mohebbi,M.H., Patel,R.S., Brammer,L., Smolinski,M.S. and Brilliant,L. (2009) Detecting influenza epidemics using search engine query data. Nature 457, 1012-1014. Hahn,W., Morley,C.P., Morrow,C. and Epling,J.W. (2009) The effect of media attention on concern for and medical management of methicillin-resistant Staphylococcus aureus: a multimethod study. J Public Health Manag. Pract. 15, 150-159. Hota,B., Blom,D.W., Lyle,E.A., Weinstein,R.A. and Hayden,M.K. (2009) Interventional evaluation of environmental contamination by vancomycin-resistant enterococci: failure of personnel, product, or procedure? J Hosp Infect 71, 123-131. Indra,A., Lassnig,H., Baliko,N., Much,P., Fiedler,A., Huhulescu,S. and Allerberger,F. (2009) Clostridium difficile: a new zoonotic agent? Wien. Klin. Wochenschr. 121, 91-95. Merlin,M.A., Wong,M.L., Pryor,P.W., Rynn,K., Marques-Baptista,A., Perritt,R., Stanescu,C.G. and Fallon,T. (2009) Prevalence of methicillin-resistant Staphylococcus aureus on the stethoscopes of emergency medical services providers. Prehosp. Emerg Care 13, 71-74. Otter,J.A., Havill,N.L., Boyce,J.M. and French,G.L. (2009) Comparison of community-associated meticillin-resistant Staphylococcus aureus from teaching hospitals in London and the USA, 2004-2006: where is USA300 in the UK? Eur. J Clin Microbiol Infect Dis. Piper,C., Cotter,P.D., Ross,R.P. and Hill,C. (2009) Discovery of medically significant lantibiotics. Curr Drug Discov. Technol. 6, 1-18. Pu,S., Han,F. and Ge,B. (2009) Isolation and characterization of methicillin-resistant Staphylococcus aureus strains from Louisiana retail meats. Appl. Environ. Microbiol 75, 265-267. Roberts,M.C., Soge,O.O., Giardino,M.A., Mazengia,E., Ma,G. and Meschke,J.S. (2009) Vancomycin-resistant Enterococcus spp. in marine environments from the West Coast of the USA. J Appl. Microbiol. Sethi,A.K., Al-Nassir,W.N., Nerandzic,M.M. and Donskey,C.J. (2009) Skin and environmental contamination with vancomycin-resistant Enterococci in patients receiving oral metronidazole or oral vancomycin treatment for Clostridium difficile-associated disease. Infect Control Hosp Epidemiol. 30, 13-17. Stepanovic,S., Cirkovic,I., Djukic,S., Vukovic,D. and Svabic-Vlahovic,M. (2008) Public transport as a reservoir of methicillin-resistant staphylococci. Lett Appl. Microbiol 47, 339-341. Treakle,A.M., Thom,K.A., Furuno,J.P., Strauss,S.M., Harris,A.D. and Perencevich,E.N. (2009) Bacterial contamination of health care workers' white coats. Am J Infect Control 37, 101-105. Willemse-Erix,D.F., Scholtes-Timmerman,M.J., Jachtenberg,J.W., van Leeuwen,W.B., Horst-Kreft,D., Bakker Schut,T.C., Deurenberg,R.H., Puppels,G.J., van,B.A., Vos,M.C. and Maquelin,K. (2009) Optical fingerprinting in bacterial epidemiology: Raman spectroscopy as a real-time typing method. J Clin Microbiol 47, 652-659. |
Quick Links
|


